Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for AF4, a proto-oncoprotein associated with pediatric and adult leukemia.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for ENL, a proto-oncoprotein associated with pediatric and adult leukemia.
Stanford scientists in Dr. Liqun Luo's laboratory have developed a patented method for site-directed somatic cell recombination and concurrent labeling of "knock in" cells.
Monoclonal antibody that recognizes MLL, an oncoprotein that is mutated in a broad subset of pediatric and adult leukemias. MLL protein displays histone methyltransferase activity.
Rat monoclonal antibody isotype IgG2a (clone #153) recognizes the HA peptide sequence [YPYDVPDYA] derived from the influenza hemagglutinin protein. The HA peptide can be added to unrelated proteins through recombinant techniques.
Hybridoma cells for the production of monoclonal antibodies against C-terminal fragment of fly patched were made by fusion of spleen cells from an immune mouse and sp2/0 myeloma cells.
Murine Monoclonal Anitbodies Against Normal Malignant Human T-Cells. (Leu-9)
Lab designation: SBCV9.1, This hybridoma produces a monoclonal antibody IgG2b against normal and malignant human T cells. It appears to be an equivalent of anti-Leu-9.
12E7 antibody that can be used to diagnose and differentiation of peripheral ectodermal tumors (PNET) and Ewing's sarcomas, as well as in therapeutic applications and bone marrow transplantation.
Lab Designation: RB6 8C5; A rat-mouse hybridoma cell line producing a monoclonal IgG2b rat AB which recognizes most, if not all, granuloytes and granolucyte precursors in the mouse bone marrow.
Lab designation: RA3 6B2; A rat-mouse hybridoma cell line producing a monoclonal IgG2a rat AB which recognizes a B cell specific form of the T200 family of cell surface glycoproteins. B220 was first characterized by another MAB, RA3-3A1.
The 4G7 hybridoma secretes an IgG1 antibody that is specific for normal and malignant B lymphocytes and can be used for the study of B cell differentiation and for the characterization of lymphoid malignancies.
This antibody(MEL-14) is specific for a single class of lymphocyte surface molecules that appear to mediate recognition of lymph node high endothelial venules and that appear to be required for lymphocyte homing to lymph nodes in vivo.